276 related articles for article (PubMed ID: 19810777)
1. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.
Cook DM; Gurugubelli RK; Bero LA
Drug Saf; 2009; 32(11):1057-66. PubMed ID: 19810777
[TBL] [Abstract][Full Text] [Related]
2. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
[TBL] [Abstract][Full Text] [Related]
3. Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.
Daval CJR; Teng TW; Russo M; Kesselheim AS
JAMA Health Forum; 2023 Jul; 4(7):e231718. PubMed ID: 37418270
[TBL] [Abstract][Full Text] [Related]
4. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Yeh JS; Sarpatwari A; Kesselheim AS
Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
[TBL] [Abstract][Full Text] [Related]
5. Timing of new black box warnings and withdrawals for prescription medications.
Lasser KE; Allen PD; Woolhandler SJ; Himmelstein DU; Wolfe SM; Bor DH
JAMA; 2002 May; 287(17):2215-20. PubMed ID: 11980521
[TBL] [Abstract][Full Text] [Related]
6. Messages about black-box warnings: a comparative analysis of reports from the FDA and lay media in the US.
Yong PL; Bigman C; Flynn DN; Mittermaier D; Long JA
Drug Saf; 2009; 32(12):1147-57. PubMed ID: 19916582
[TBL] [Abstract][Full Text] [Related]
7. Association between FDA black box warnings and Medicare formulary coverage changes.
Dhruva SS; Karaca-Mandic P; Shah ND; Shaw DL; Ross JS
Am J Manag Care; 2017 Sep; 23(9):e310-e315. PubMed ID: 29087169
[TBL] [Abstract][Full Text] [Related]
8. The Drug Safety and Risk Management Advisory Committee: a case study of meeting frequency, content, and outcomes before and after FDAAA.
Morrato EH; Ling SB
Med Care; 2012 Nov; 50(11):970-86. PubMed ID: 23047787
[TBL] [Abstract][Full Text] [Related]
9. New and incremental FDA black box warnings from 2008 to 2015.
Solotke MT; Dhruva SS; Downing NS; Shah ND; Ross JS
Expert Opin Drug Saf; 2018 Feb; 17(2):117-123. PubMed ID: 29215916
[TBL] [Abstract][Full Text] [Related]
10. Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals.
Frank C; Himmelstein DU; Woolhandler S; Bor DH; Wolfe SM; Heymann O; Zallman L; Lasser KE
Health Aff (Millwood); 2014 Aug; 33(8):1453-9. PubMed ID: 25092848
[TBL] [Abstract][Full Text] [Related]
11. US Food and Drug Administration Black Box Warnings.
Smith RG
J Am Podiatr Med Assoc; 2020 Jan; 110(1):Article10. PubMed ID: 32073327
[TBL] [Abstract][Full Text] [Related]
12. Black-Box Warnings of Antiseizure Medications: What is Inside the Box?
Wahab A; Iqbal A
Pharmaceut Med; 2023 May; 37(3):233-250. PubMed ID: 37119452
[TBL] [Abstract][Full Text] [Related]
13. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
Nguyen NT; Cook DM; Bero LA
Clin Ther; 2006 Aug; 28(8):1231-1243. PubMed ID: 16982301
[TBL] [Abstract][Full Text] [Related]
14. Impact of FDA black box advisory on antipsychotic medication use.
Dorsey ER; Rabbani A; Gallagher SA; Conti RM; Alexander GC
Arch Intern Med; 2010 Jan; 170(1):96-103. PubMed ID: 20065205
[TBL] [Abstract][Full Text] [Related]
15. How the FDA manages drug safety with black box warnings, use restrictions, and drug removal, with attention to gastrointestinal medications.
Ehrenpreis ED; Ciociola AA; Kulkarni PM;
Am J Gastroenterol; 2012 Apr; 107(4):501-4. PubMed ID: 22475958
[No Abstract] [Full Text] [Related]
16. The "black box" warning and allergy drugs.
Aaronson DW
J Allergy Clin Immunol; 2006 Jan; 117(1):40-4. PubMed ID: 16387582
[TBL] [Abstract][Full Text] [Related]
17. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
Wang LM; Wong M; Lightwood JM; Cheng CM
Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
[TBL] [Abstract][Full Text] [Related]
18. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.
Zhang AD; Schwartz JL; Ross JS
Milbank Q; 2019 Sep; 97(3):796-819. PubMed ID: 31304643
[TBL] [Abstract][Full Text] [Related]
19. An Audit of Black Box Warnings (BBWs) in the United States Food and Drug Administration (US-FDA) Database - A Five-Year Analysis.
Bose D; Gogtay N; Goel T; Konwar M
Curr Drug Saf; 2022; 17(1):54-58. PubMed ID: 34382527
[TBL] [Abstract][Full Text] [Related]
20. Black box warnings: what do they mean to pharmacists and patients.
Martin CM; Borgelt L
Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
